Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Toronto
$27,000.00
Menopause Type and Estrogen Delivery Route Differentially Modulate Cognitive Decline and Neurogenesis in Female Alzheimer’s-Risk Models
FY 2025-26
Summary
Alzheimer’s disease is the most common form of dementia, affecting nearly half a million people in Canada. About two-thirds of these cases occur in women, yet there is a lack of sex-specific research on why this disparity exists. Menopause is a key time for intervention because brain changes linked to Alzheimer’s can begin up to 20 years before diagnosis, around the same time many women reach menopause. Menopausal hormone therapies are widely used to treat menopausal symptoms, but findings are mixed on whether they protect memory. Additionally, the route of estrogen administration matters, as the most potent estrogen, estradiol, may reach the brain more effectively when administered under the skin versus orally. One major gap is that most studies have not compared different types of menopause or routes of estradiol delivery within the same study design.
This project will test how the type of menopause and route of estradiol administration affect memory and growth of new neurons (neurogenesis). Using a mouse model that carries human genes linked to higher Alzheimer’s risk, we will compare two menopause models: surgical removal of the ovaries, and natural (spontaneous) menopause. After menopause is induced, mice will receive either oral estradiol, estradiol under the skin, or a control treatment for one month. At 12 months of age, we will assess pattern separation, a form of memory that depends on the hippocampus, a key region for neurogenesis, and then examine brain tissue.
By identifying which combinations of menopause type and estrogen delivery best preserve memory and growth of new neurons, this work aims to guide more personalized hormone therapy strategies that reduce memory loss and lower Alzheimer’s disease risk in women during and after menopause.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
573328
Name
Teeter Erika
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Menopause Type and Estrogen Delivery Route Differentially Modulate Cognitive Decline and Neurogenesis in Female Alzheimer’s-Risk Models
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Alzheimer'S Disease; Apoee4; Estradiol; Female Aging; Hippocampus; Hormone Therapy; Menopause; Neurogenesis; Pattern Separation; Sex-Specific Differences
Abstract
Alzheimer’s disease is the most common form of dementia, affecting nearly half a million people in Canada. About two-thirds of these cases occur in women, yet there is a lack of sex-specific research on why this disparity exists. Menopause is a key time for intervention because brain changes linked to Alzheimer’s can begin up to 20 years before diagnosis, around the same time many women reach menopause. Menopausal hormone therapies are widely used to treat menopausal symptoms, but findings are mixed on whether they protect memory. Additionally, the route of estrogen administration matters, as the most potent estrogen, estradiol, may reach the brain more effectively when administered under the skin versus orally. One major gap is that most studies have not compared different types of menopause or routes of estradiol delivery within the same study design.
This project will test how the type of menopause and route of estradiol administration affect memory and growth of new neurons (neurogenesis). Using a mouse model that carries human genes linked to higher Alzheimer’s risk, we will compare two menopause models: surgical removal of the ovaries, and natural (spontaneous) menopause. After menopause is induced, mice will receive either oral estradiol, estradiol under the skin, or a control treatment for one month. At 12 months of age, we will assess pattern separation, a form of memory that depends on the hippocampus, a key region for neurogenesis, and then examine brain tissue.
By identifying which combinations of menopause type and estrogen delivery best preserve memory and growth of new neurons, this work aims to guide more personalized hormone therapy strategies that reduce memory loss and lower Alzheimer’s disease risk in women during and after menopause.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Teeter, Erika
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~